These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8033110)

  • 21. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells.
    Lang D; Miknyoczki SJ; Huang L; Ruggeri BA
    Oncogene; 1998 Mar; 16(12):1593-602. PubMed ID: 9569027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival.
    Sessa F; Bonato M; Bisoni D; Ranzani GN; Capella C
    Eur J Histochem; 1998; 42 Spec No():67-76. PubMed ID: 10076772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
    Tsujiuchi T; Sasaki Y; Kubozoe T; Konishi Y; Tsutsumi M
    Mol Carcinog; 2003 Feb; 36(2):60-6. PubMed ID: 12557261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic adenocarcinomas frequently show p53 gene mutations.
    Scarpa A; Capelli P; Mukai K; Zamboni G; Oda T; Iacono C; Hirohashi S
    Am J Pathol; 1993 May; 142(5):1534-43. PubMed ID: 8494051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
    Chang BK; Gutman R
    Cancer Res; 1982 Jul; 42(7):2666-70. PubMed ID: 6805945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The significance of p53 gene mutations and expressions in human colorectal tumors].
    Qian H; Yu B; Zhou X
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA
    Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12.
    Fujii H; Egami H; Chaney W; Pour P; Pelling J
    Mol Carcinog; 1990; 3(5):296-301. PubMed ID: 2173932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantable ductal adenocarcinoma of the Syrian hamster pancreas.
    Scarpelli DG; Rao MS
    Cancer Res; 1979 Feb; 39(2 Pt 1):452-8. PubMed ID: 216489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence.
    Sarabia SF; Liehr JG
    Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular pathways of pancreatic carcinogenesis].
    Torrisani J; Buscail L
    Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of the Rassf1a gene and its aberrant DNA methylation in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
    Shimizu K; Itsuzaki Y; Fujii H; Honoki K; Tsujiuchi T
    Mol Carcinog; 2008 Feb; 47(2):80-7. PubMed ID: 17849420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer.
    Mironov NM; Aguelon MA; Potapova GI; Omori Y; Gorbunov OV; Klimenkov AA; Yamasaki H
    Cancer Res; 1994 Jan; 54(1):41-4. PubMed ID: 8261459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
    Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
    Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.